Paper - WANFANG MED ONLINE

You Position: Home > Paper

Effect of monoclonal antibody 3A5 coupled with Chinese medicine com-pound Andi in targeted treatment of hepatocellular carcinoma

( views:247, downloads:0 )

Author:: No author available

Journal Title:: WORLD CHINESE JOURNAL OF DIGESTOLOGY

Issue:: 4

DOI:: 10.3969/j.issn.1009-3079.2003.04.007

Key Word:: No keyword available

Abstract：目的:探讨单克隆抗体3A5-复方中药安迪粉针剂偶联物(3A5-Andi)的肝癌导向治疗作用.方法:用单克隆抗体3A5与安迪粉针剂(Andi)制备偶联物,ELISA检测3A5-Andi偶联物保持对人肝癌BEL-7402细胞的免疫反应性;采用小鼠/裸鼠移植性肿瘤模型,5-FU为阳性对照组,观察12、24和50mg/kg的导向治疗作用.结果:克隆生成法显示,3A5-Andi具有比Andi更强的细胞毒性,二者的IC50分别为2.8 mg/L和5.1 mg/L(P＜0.01).24 mg/kg和50 mg/kg3A5-Andi ip对小鼠移植性腹水型H22肝癌的生命延长率(LPR)分别为133%和167%(P＜0.05);而12mg/kg和24mg/kgAndi的LPR分别为112%和138%(P＜0.05).24 mg/kg 3A5-Andi和12 mg/kg Andi iv对裸鼠移植性人肝癌BEL-7402细胞瘤的瘤重抑制率分别为63.5%和52.2%(P＞0.05).24 mg/kg 3A5-Andi和12 mg/kg Andipt对BEL-7402人肝癌的抑制率分别为75.4%和61.0%(P＞0.05).结论:3A5-Andi偶联物具有一定的肿瘤导向治疗作用;3A5-Andi与Andi比较,3A5-Andi对裸鼠移植人肝癌BEL-7402具有较强的治疗作用;pt方式3A5-Andi比iv疗效更好.

Reference

[1]韩聚强,胡聪,刘树贤,等.复方中药体外保护肝细胞的机制[J].2001,(8).
[2]Lian Jun Yang,Yan Fang Sui,Zhi Nan Chen.Preparation and activity of conjugate of monoclonal antibody HAbl8 against hepatoma F(ab')2 fragment and staphylococcal enterotoxin A[J].2001,(2).
[3]李明远,李虹,肖丽英,等.CD3AK细胞冻融提取液的抗肿瘤活性研究[J].2000,(1).
[4]孟志强,郭伟剑,于尔辛,等.健脾理气方药物血清对肝癌细胞端粒酶活性及凋亡的影响[J].2000,(8).
[5]肖正明,宋景贵,徐朝晖,等.黄芪水提物对体外培养人肝癌细胞增殖及代谢的影响[J].2000,(1).
[6]司维柯,潘静,陆华,等.苦参碱抑制HepG2细胞增殖及其剂量与抑制方式关系的研究[J].2001,(2).
[7]蒋平,何生,章崇杰,等.半乳糖基抗CD3单抗-TIL体外趋肝性研究[J].1999,(1).
[8]樊俊杰,贾正平,谢景文,等.瑞香狼毒小鼠药物血清协同细胞毒化疗药物抗肝癌及机制研究[J].2001,(9).
[9]刘小云,尚伯扬,刘秀均,等.应用平阳霉素与单克隆抗体Fab′片段偶联物抑制肝癌生长与肿瘤肝转移[J].2001,(4).
[10]Lian-Jun Yang,Wen-Liang Wang.Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization[J].2002,(5).
[11]姜世明,肖正明,宋景贵,等.土贝母水提物对体外培养人肝癌细胞增殖及代谢的影响[J].2000,(3).
[12]郭伟剑,于尔辛,郑颂国,等.健脾理气药诱导人肝癌细胞SMMC7721凋亡的研究[J].2000,(1).
[13]梁军,孙纪元,谢艳华,等.中药安迪对HL-60细胞分化的诱导作用[J].2002,(4).
[14]石灵春,吴万垠,张维彬,等.莪术油对小鼠肝癌增殖细胞核抗原的影响[J].1999,(2).
[15]黄正明,杨新波,曹文斌,等.芹灵冲剂在2215细胞培养内对HBsAg,HBeAg的抑制作用[J].2000,(2).
[16].Direct Technetium-99m Labeling of Anti-Hepatoma Monoclonal Antibody Fragment: A Radioimmunoconjugate for Hepatocellular Carcinoma Imaging[J].2000,(3).
[17]L, Mohr,J I, Schauer,R H, Boutin,etc.Targeted gene transfer to hepatocellular carcinoma cells in vitro using a novel monoclonal antibody-based gene delivery system.[J].1999,29.
[18]Yasuhiro Yoshida,Mitsuru Myozaki,Etushi Kuroda,etc.Cytotoxic Effect of an Anti-Liver Monoclonal Autoantibody obtained after Neonatal Thymectomy in Mice[J].2001,16(4).
[19]Koning GA,Morselt HW,Gorter A,etc.Pharmacokinetics of differently designed immunoliposome formulations in rats with or without hepatic colon cancer metastases.[J].2001,18(9).
[20]N, Oriuchi.[Immunoscintigraphy and radioimmunotherapy of cancer using monoclonal antibodies].[J].1999,26.
[21]Kazuhito Yamamoto,Kazuya Kitamura,Satoki Nishida,etc.Iodine-131 human-mouse chimeric Fab monoclonal antibody A7 guided surgery for colorectal cancer patients: A pilot study[J].1999,29(2).
[22]S Y, You,C Y, Zhang,X P, Yi,etc.Evaluation of clinical significance of isoferritin by development of new monoclonal antibodies specific for acidic isoferritin.[J].2001,20.
[23]Tsutsui H,Suda T,Nakanishi K,etc.Prevention of hepatocellular carcinoma development associated with chronic hepatitis by anti-fas ligand antibody therapy.[J].2002,196(8).
[24]Shigeoka Hironori,Karsten Uwe,Okuno Kiyotaka,etc.Inhibition of Liver Metastases from Neuraminidase-Treated Colon 26 Cells by an Anti-Thomsen-Friedenreich-Specific Monoclonal Antibody[J].1999.
[25]B M, Chen,T L, Cheng,S C, Tzou,etc.Potentiation of antitumor immunity by antibody-directed enzyme prodrug therapy.[J].2001,94.